714 related articles for article (PubMed ID: 27385177)
41. Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes.
Schaefer M; Morinaga G; Matsui A; Schänzle G; Bischoff D; Süssmuth RD
Drug Metab Dispos; 2018 Feb; 46(2):166-177. PubMed ID: 29212823
[TBL] [Abstract][Full Text] [Related]
42. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
[TBL] [Abstract][Full Text] [Related]
43. Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.
Lee CA; O'Connor MA; Ritchie TK; Galetin A; Cook JA; Ragueneau-Majlessi I; Ellens H; Feng B; Taub ME; Paine MF; Polli JW; Ware JA; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2015 Apr; 43(4):490-509. PubMed ID: 25587128
[TBL] [Abstract][Full Text] [Related]
44. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
45. Prediction of the Transporter-Mediated Drug-Drug Interaction Potential of Dabrafenib and Its Major Circulating Metabolites.
Ellens H; Johnson M; Lawrence SK; Watson C; Chen L; Richards-Peterson LE
Drug Metab Dispos; 2017 Jun; 45(6):646-656. PubMed ID: 28320730
[TBL] [Abstract][Full Text] [Related]
46. Membrane transport as a determinant of the hepatic elimination of drugs and metabolites.
Evans AM
Clin Exp Pharmacol Physiol; 1996; 23(10-11):970-4. PubMed ID: 8911743
[TBL] [Abstract][Full Text] [Related]
47. Species differences in drug transporters and implications for translating preclinical findings to humans.
Chu X; Bleasby K; Evers R
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):237-52. PubMed ID: 23256482
[TBL] [Abstract][Full Text] [Related]
48. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs.
Nies AT; Schwab M; Keppler D
Expert Opin Drug Metab Toxicol; 2008 May; 4(5):545-68. PubMed ID: 18484914
[TBL] [Abstract][Full Text] [Related]
49. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
51. The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions.
Kovacsics D; Patik I; Özvegy-Laczka C
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):409-424. PubMed ID: 27783531
[TBL] [Abstract][Full Text] [Related]
52. Up-regulation of renal Mdr1 and Mrp2 transporters during amiodarone pretreatment in rats.
Cermanova J; Fuksa L; Brcakova E; Hroch M; Kucera O; Kolouchova G; Hirsova P; Malakova J; Staud F; Martinkova J; Cervinkova Z; Micuda S
Pharmacol Res; 2010 Feb; 61(2):129-35. PubMed ID: 19703566
[TBL] [Abstract][Full Text] [Related]
53. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
54. Mechanistic Basis of Cabotegravir-Glucuronide Disposition in Humans.
Patel M; Eberl HC; Wolf A; Pierre E; Polli JW; Zamek-Gliszczynski MJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):269-277. PubMed ID: 31175220
[TBL] [Abstract][Full Text] [Related]
55. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.
Marquez B; Van Bambeke F
Curr Drug Targets; 2011 May; 12(5):600-20. PubMed ID: 21039335
[TBL] [Abstract][Full Text] [Related]
56. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
57. Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers.
Bonnaventure P; Cusin F; Pastor CM
Drug Metab Dispos; 2019 Apr; 47(4):412-418. PubMed ID: 30674615
[TBL] [Abstract][Full Text] [Related]
58. A perspective on efflux transport proteins in the liver.
Köck K; Brouwer KL
Clin Pharmacol Ther; 2012 Nov; 92(5):599-612. PubMed ID: 22948894
[TBL] [Abstract][Full Text] [Related]
59. Efflux and uptake transporters involved in the disposition of bazedoxifene.
Lušin TT; Mrhar A; Stieger B; Kristl A; Berginc K; Trontelj J
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):251-7. PubMed ID: 25631963
[TBL] [Abstract][Full Text] [Related]
60. Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition.
Lundquist P; Englund G; Skogastierna C; Lööf J; Johansson J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):448-58. PubMed ID: 24396144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]